Back to Search
Start Over
Fasting glycemia: a good predictor of weight loss after RYGB.
- Source :
-
Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery [Surg Obes Relat Dis] 2014 May-Jun; Vol. 10 (3), pp. 419-24. Date of Electronic Publication: 2013 Nov 21. - Publication Year :
- 2014
-
Abstract
- Background: Preoperative prediction of weight loss after Roux-en-Y gastric bypass (RYGB) could help surgeons in managing surgical lists and patients' expectations. The objective of this study was to understand if preoperative metabolic control might improve surgical results.<br />Methods: Prospective cohort of 163 consecutive patients who underwent RYGB with at least 1 year of follow-up.<br />Results: Most patients were female (90.2%), with a mean age of 38 (19-60) and a BMI of 46.0 (34.3-59.9) kg/m(2). After 12 months, the mean body mass index (BMI) was 29.7 kg/m(2) (21.5-39.9) with a corresponding percentage of excess weight lost (%EWL) of 78.8% and a percentage of weight loss (%WL) of 35.1%. Patients with the highest preoperative fasting blood glucose (FBG) were older (42 versus 36; P<.001); were more likely to have type 2 diabetes (T2 DM, 40% versus 6.8%; P<.001) and metabolic syndrome (89% versus 25%; P<.001), had a slightly higher BMI (30.8 versus 29.3 kg/m(2); P = .03), and had achieved a significantly lower %EWL and %WL at 12 months (72.5% versus 81.2%; P = .004; 33.2 versus 35.9%; P = .03, respectively). We observed a dose-response effect with increasing FBG (<85 mg/dL, 85-100 mg/dL, and ≥ 100 mg/dL, respectively), with 83.5%, 80.0%, and 72.5% (P = .009) of %EWL at 12 months. By multivariate logistic regression, initial BMI and FBG>100, were the only variables related (inversely) with the probability of achieving a %EWL>80 or %WL>35. This effect was not detected in patients receiving oral antidiabetic medications.<br />Conclusion: Higher preoperative FBG is independently related to a poorer weight loss 12 months after RYGB; this suggests the need to offer earlier surgical intervention for severely obese patients with impairment of glucose metabolism. The potential for less weight loss in patients with a higher FBG should not discourage RYGB, given the significant metabolic improvement after surgery.<br /> (© 2013 American Society for Bariatric Surgery Published by American Society for Metabolic and Bariatric Surgery All rights reserved.)
- Subjects :
- Adult
Biomarkers blood
Body Mass Index
C-Peptide blood
Chromatography, High Pressure Liquid
Chromatography, Ion Exchange
Female
Follow-Up Studies
Humans
Hypoglycemia etiology
Immunoassay
Insulin blood
Male
Middle Aged
Obesity, Morbid blood
Postoperative Period
Preoperative Period
Prospective Studies
Time Factors
Treatment Outcome
Young Adult
Blood Glucose metabolism
Fasting blood
Gastric Bypass methods
Hypoglycemia blood
Laparoscopy
Obesity, Morbid surgery
Weight Loss physiology
Subjects
Details
- Language :
- English
- ISSN :
- 1878-7533
- Volume :
- 10
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery
- Publication Type :
- Academic Journal
- Accession number :
- 24462312
- Full Text :
- https://doi.org/10.1016/j.soard.2013.11.005